Additional information
| Active substance | Trastuzumab |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | HER2 testing (immunohistochemistry or fluorescence in situ hybridization) |
| Also known as | rhuMAb HER2 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause hypertension |
| Trade name | Herceptin |
| Storage conditions | Store refrigerated at 2-8В°C (36-46В°F) |
| Chemical name | Trastuzumab |
| Formula | C6484H9996N1720O2014S44 |
| Substance class | Monoclonal antibody |
| Main action | HER2/neu receptor antagonist |
| Half-life | Approximately 28 days |
| Dosage (medical) | Typically 4 mg/kg as a loading dose followed by 2 mg/kg weekly or 6 mg/kg every three weeks |
| Dosage (sports) | Not applicable |
| Effects | Reduction in tumor growth, improved survival in breast cancer patients |
| Side effects | Fever, nausea, vomiting, infusion reactions, cardiotoxicity |
| Use in sports | None |
| Manufacturer | Roche |
Lasix Sanofi
Muscoflex 8 mg Bilim
Champix 56 tabs Pfizer
Legendary Bulking Cycle Ultima Pharmaceuticals
Spiriva HandiHaler 18mg Boehringer Ingelheim
FUCIDIN 500 mg Abdi Ibragim
Tavanic 500 mg Sanofi
Balkan Pharma Strombafort 10mg 100 Tabletten
Prograf 1mg Astellas Pharma
Zimaks 400 Bilim
AVELOX 400 Bayer
Norvacs 5 mg Pfizer
DELETE - Micardis 80 mg Boehringer Ingelheim
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
Norvacs 10 mg Pfizer
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Rovamycine 3.000.000 iu Eczacibasi
Fostimon (Merional) 75 (HMG) IBSA 

Reviews
There are no reviews yet.